These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27330755)

  • 1. The role of microRNAs in gallbladder cancer.
    Yang G; Zhang L; Li R; Wang L
    Mol Clin Oncol; 2016 Jul; 5(1):7-13. PubMed ID: 27330755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Factors and MicroRNAs in the Development of Gallbladder Cancer: The Prospective Clinical Targets.
    Quraishi R; Sanyal S; Dwivedi M; Moitra M; Dwivedi M
    Curr Drug Targets; 2024; 25(6):375-387. PubMed ID: 38544392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential role of miRNAs in the pathogenesis of gallbladder cancer - A focus on signaling pathways interplay.
    Doghish AS; Midan HM; Elbadry AMM; Darwish SF; Rizk NI; Ziada BO; Elbokhomy AS; Elrebehy MA; Elballal MS; El-Husseiny HM; Abdel Mageed SS; Abulsoud AI
    Pathol Res Pract; 2023 Aug; 248():154682. PubMed ID: 37451195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA aberrations: An emerging field for gallbladder cancer management.
    Chandra V; Kim JJ; Mittal B; Rai R
    World J Gastroenterol; 2016 Feb; 22(5):1787-99. PubMed ID: 26855538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4.
    Niu J; Li Z; Li F
    Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G670-G681. PubMed ID: 31369289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of MicroRNAs in Hepatocellular Carcinoma.
    Zhu Z; Zhang X; Wang G; Zheng H
    Hepat Mon; 2014 Aug; 14(8):e18672. PubMed ID: 25337143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer.
    Zhang M; Gong W; Zuo B; Chu B; Tang Z; Zhang Y; Yang Y; Zhou D; Weng M; Qin Y; Ma M; Jiang A; Ma F; Quan Z
    Oncotarget; 2016 Nov; 7(48):78640-78652. PubMed ID: 27769047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA signatures in total peripheral blood of gallbladder cancer patients.
    Li G; Pu Y
    Tumour Biol; 2015 Sep; 36(9):6985-90. PubMed ID: 25861754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.
    Bao RF; Shu YJ; Hu YP; Wang XA; Zhang F; Liang HB; Ye YY; Li HF; Xiang SS; Weng H; Cao Y; Wu XS; Li ML; Wu WG; Zhang YJ; Jiang L; Dong Q; Liu YB
    Oncotarget; 2016 Apr; 7(16):22339-54. PubMed ID: 26968949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA expression and its implications for diagnosis and therapy of gallbladder cancer.
    Li Z; Yu X; Shen J; Law PT; Chan MT; Wu WK
    Oncotarget; 2015 Jun; 6(16):13914-21. PubMed ID: 26040010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
    Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
    J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-20a triggers metastasis of gallbladder carcinoma.
    Chang Y; Liu C; Yang J; Liu G; Feng F; Tang J; Hu L; Li L; Jiang F; Chen C; Wang R; Yang Y; Jiang X; Wu M; Chen L; Wang H
    J Hepatol; 2013 Sep; 59(3):518-27. PubMed ID: 23665284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging role of long non-coding RNA in gallbladder cancer pathogenesis.
    Khandelwal A; Malhotra A; Jain M; Vasquez KM; Jain A
    Biochimie; 2017 Jan; 132():152-160. PubMed ID: 27894946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential.
    Asiaf A; Ahmad ST; Arjumand W; Zargar MA
    Methods Mol Biol; 2018; 1699():23-43. PubMed ID: 29086366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway.
    Shu YJ; Bao RF; Jiang L; Wang Z; Wang XA; Zhang F; Liang HB; Li HF; Ye YY; Xiang SS; Weng H; Wu XS; Li ML; Hu YP; Lu W; Zhang YJ; Zhu J; Dong P; Liu YB
    Cell Death Differ; 2017 Mar; 24(3):445-457. PubMed ID: 28060377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profile of MicroRNA: An Emerging Hallmark of Cancer.
    Zaheer U; Faheem M; Qadri I; Begum N; Yassine HM; Al Thani AA; Mathew S
    Curr Pharm Des; 2019; 25(6):642-653. PubMed ID: 30914015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1.
    Lu W; Hu Y; Ma Q; Zhou L; Jiang L; Li Z; Zhao S; Xu Y; Shi W; Li S; Liu Y
    Oncotarget; 2016 Sep; 7(38):62364-62376. PubMed ID: 27577078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in the pathogenesis of renal cell carcinoma and their diagnostic and prognostic utility as cancer biomarkers.
    Fedorko M; Pacik D; Wasserbauer R; Juracek J; Varga G; Ghazal M; Nussir MI
    Int J Biol Markers; 2016 Feb; 31(1):e26-37. PubMed ID: 26481440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.
    Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs: novel regulators in the hallmarks of human cancer.
    Ruan K; Fang X; Ouyang G
    Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.